Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition

Gynecological Endocrinology

Volumn 31, Issue 3, 2015, Pages 237-242

  Kogure, Gislaine Satyko ^a   Silva, Rafael Costa ^a   Picchi Ramos, Fabiene K ^a   Miranda Furtado, Cristiana Libardi ^a   Lara, Lucia Alves Da Silva ^a   Ferriani, Rui Alberto ^a   Dos Reis, Rosana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Body composition; Insulin resistance and hyperandrogenism; Muscle strength; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ANDROGEN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BICEPS BRACHII MUSCLE; BODY COMPOSITION; BODY FAT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; GRIP STRENGTH; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC PARAMETERS; MUSCLE MASS; MUSCLE STRENGTH; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; BLOOD; HAND STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANDROGENS; BODY COMPOSITION; CASE-CONTROL STUDIES; FEMALE; HAND STRENGTH; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE STRENGTH; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84931453357     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.982083     Document Type: Article

References (28)

1. Consensus-PCOS-Rotterdam. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-Term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
2. March WA, Moore VM, Willson KJ, Phillips DIW. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-51.
3. Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 2003; 79: 1358-64.
4. Karabulut A, Yaylali GF, Demirlenk S, et al. Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance. Gynecol Endocrinol 2012; 28: 111-14.
5. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 2002; 77: S34-41.
6. Kogure GS, Piccki FK, Viera CS, et al. Analysis of muscle strength and body composition of women with polycystic ovary syndrome. Rev Bras Ginecol Obstet 2012; 34: 316-22.
7. Bashin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005; 90: 678-88.
8. Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci 1992; 17: 338-45.
9. Ferriman DM, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocinol Metab 1961; 21: 1440-7.
10. Cascella T, Palomba S, TauchmanovàL, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2006; 91: 4395-400.
11. Genton L, Hans D, Kyle UG, Pichard C. Dual- energy X-ray absorptiometry and body composition: differences between devices and comparison with reference methods. Nutrition 2002; 18: 66-70.
12. Kelly TL. Technical considerations in advanced clinical body composition evaluation [internet]. Hologic, Inc., Bedford, MA. Available from: http://www.hologic.com/data/Technical-Considerations-Advanced-Body-Composition-Assessment.pdf [last accessed 17 Feb 2014]
13. Geloneze B, Repetto EM, Geloneze SR, et al. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006; 72: 219-20.
14. Raso V, Matsudo SMM, Matsudo VKR. Experiência De mulheres idosas em programas De exercícios com pesos não determina a performance no teste 1- RM nem a resposta da percepção subjetiva De esforço. Rev Bras Ciên Esp 2002; 23: 81-92.
15. Matuszak ME, Fry AC, Weiss LW, et al. Effect of rest interval length on repeated 1 repetition maximum back squats. J Strength Cond Res 2003; 17: 634-7.
16. Heyward VH. Advanced fitness assessment and exercise prescription. 6th ed. Champaign (IL): Human Kinetics, 2010.
17. SAS Institute Inc. SAS/STAT- user's guide. Version 9.0. Cary, NC: SAS Institute Inc.; 1999.
18. Lord J, Thomas R, Fox B, et al. The central issue?. Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 2006; 113: 1203-9.
19. Premoli AC, Santana LF, Ferriani RA, et al. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil Steril 2005; 83: 1852-5.
20. Thomson RL, Buckley JD, Moran LJ, et al. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG 2009; 116: 1242-50.
21. Soyupek F, Guney M, Eris S, et al. Evaluation of hand functions in women with polycystic ovary syndrome. Gynecol Endocrinol 2008; 24: 571-5.
22. Häkkinen K, Pakarinen A, Kraemer WJ, et al. Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women. J Appl Physiol 2001; 91: 569-80.
23. Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000; 15: 12-17.
24. Reis RM, Foss MC, Dias De Moura M, et al. Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism. Gynecol Endocrinol 1995; 9: 45-50.
25. Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007; 92: 2500-5.
26. Mario FM, do Amarante F, Toscani MK, Spritzer PM. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Exp Clin Endocrinol Diabetes 2012; 120: 511-16.
27. Carmina E, Guastella E, Longo RA, et al. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 2009; 161: 583-9.
28. Aydogdu A, Tasci I, Kucukerdonmez O, et al. Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Gynecol Endocrinol 2013; 29: 152-5.